Ads
related to: pfizerSCBN.org has been visited by 10K+ users in the past month
Search results
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
Motley Fool via Yahoo Finance· 7 hours agoHowever, such stocks exist. Here are three high-yield dividend stocks that could soar 22% to 49%...
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Zacks via Yahoo Finance· 4 days agoPfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings...
The Motley Fool: Pfizer offers a pfat 6.4% dividend
Dallas Morning News· 6 hours agoShares of Pfizer were recently down more than 35% over the past year — in part because the market’s enthusiasm for its COVID-19 vaccine Comirnaty and...
Pfizer Wins FDA Approval For $3.5 Million Gene Therapy, Rivaling CSL, Uniqure
Investor's Business Daily· 2 days agoThe Food and Drug Administration approved Pfizer's hemophilia B gene therapy on Friday, a one-time...
Earnings playbook: Your guide to the busiest week of the season, including Apple and Amazon
CNBC· 5 hours agoIt's the busiest week of the earnings season, and it could have major consequences for the stock...
Travis Kelce's dad's three-word response to Taylor Swift marriage claim
Newsweek· 2 days agoTravis Kelce's father has shared his thoughts on a marriage rumor surrounding his son and Taylor...
RFK Jr. repeats debunked vaccine claims in interview with Bill Maher
Salon.com· 1 day agoPresidential hopeful Robert F. Kennedy Jr. made an appearance on “Real Time with Bill Maher” on...
FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
NBC News via Yahoo News· 2 days agoThe Food and Drug Administration on Friday approved Pfizer’s treatment for a rare genetic bleeding...
What's Going On With Pfizer Stock On Thursday? By Benzinga
Investing.com· 3 days agoWhat's Going On With Pfizer Stock On Thursday?
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Benzinga via Yahoo Finance· 2 days agoFriday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate...